… after allogeneic bone marrow transplantation (BMT). … relapse- free survival from 6
months to 4 years after BMT was 85% for the mixed chimeras and 65% for the complete donor …

… disease-free survival in the good risk group were 47% and 40%, respectively, and in the poor
risk group were 25% and 21%, respectively, at a median follow-… DC is a predictor of clinical …

… donor transplantation and strategies to limit and prevent post-… chimerism (74 % vs 40 %).
Thus, persistence of host CD34 + … experience for DLI in chronic myelogenous leukemia, its use …

… Bone marrow transplant … Chronic myelogenous leukemia 2 (5) … , while 4 of our 5 patients
with follicular lymphoma continued with mixed donor chimerism with no evidence of relapse …

… improved leukemia-free survival compared to DLI in full-donor … apoptosis receptors on
acute myeloid leukaemia: high CD40 … of donor leukocytes for relapse of chronic myeloid-leukemia …

… In 2021, the European Blood and Marrow Transplantation (… F and G Comparison of donor
chimerism measured by NGS … of overt relapse, relapse-free survival, and overall survival by …

… , oncology, blood, and marrow transplantation unit. We included … (MPAL) and chronic myeloid
leukemia (CML) in blast crisis … donor chimerism on Day+60 from the bone marrow sample. …

… follow-up; disease-free survival … donor chimaerism following alemtuzumab-based
reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia …

… obtained in patients with chronic myelogenous leukemia (CML), … The main indication for
DLI treatment was relapse of the … patients with chronic myeloid leukemia) relapse after ASCT. (…

… Progression-free survival was defined as the date of … In this study full donor chimerism was
achieved in the majority of patients. The … before allogeneic blood or marrow transplantation. …